Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.

DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the ...

The study, published in the Journal of the American Chemical Society ("Graphene-Based Glucose Sensors with an Attomolar Limit of Detection") and led by Dr. Andrea Capasso at INL, introduces an ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

but you can't use it without buying a $99 two-pack of Stelo glucose biosensors to take advantage of it. Each sensor can be worn for 15 days. Stelo is not for adults who are on insulin or at risk ...

Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...